🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

18 results for “Heron” Clear

  1. APF530

    Heron Therapeutics

    Chemotherapy-induced Nausea and Vomiting

    phase 3 small molecule completed

    1 trial

  2. APF530

    Heron Therapeutics

    Nausea and Vomiting

    phase 3 small molecule completed

    1 trial

  3. Aprepitant injectable emulsion

    Heron Therapeutics

    COVID-19

    phase 2 small molecule terminated

    1 trial

  4. B10 L-BPA Injection

    Heron Therapeutics

    Malignant Brain Tumors

    phase 2 small molecule active

    1 trial

  5. B10 L-BPA Injection

    Heron Therapeutics

    Meningioma

    phase 2 small molecule completed

    1 trial

  6. Bupivacaine HCI without epinephrine

    Heron Therapeutics

    Post-Operative Pain

    phase 2 small molecule completed

    1 trial

  7. Drug: B10 L-BPA Injection

    Heron Therapeutics

    Head and Neck Cancer

    phase 2 small molecule active

    1 trial

  8. GRANISETRON EXTENDED RELEASE INJECTION (GERSC)

    Heron Therapeutics

    Chemotherapy-induced Nausea and Vomiting

    phase 2 small molecule terminated

    1 trial

  9. HTX-011A

    Heron Therapeutics

    Postoperative Pain

    phase 2 small molecule completed

    1 trial

  10. HTX-011B

    Heron Therapeutics

    Postoperative Pain

    phase 2 small molecule completed

    1 trial

  11. HTX-034

    Heron Therapeutics

    Bunions

    phase 2 small molecule completed

    1 trial

  12. Bupivacaine HCl

    Heron Therapeutics

    Analgesia

    approved small molecule completed

    1 trial

  13. Bupivacaine Hydrochloride

    Heron Therapeutics

    Analgesia

    approved small molecule active

    1 trial

  14. Bupivacaine liposome injectable suspension

    Heron Therapeutics

    Analgesia

    approved small molecule completed

    1 trial

  15. HTX-011

    Heron Therapeutics

    Postoperative Pain

    approved small molecule completed

    8 trials

  16. HTX-011

    Heron Therapeutics

    Analgesia

    approved small molecule completed

    6 trials

  17. SUSTOL

    Heron Therapeutics

    Chemotherapy-Induced Nausea and Vomiting (CINV)

    approved small molecule active

    1 trial

  18. ZYNRELEF 200Mg-6Mg Extended-Release Solution

    Heron Therapeutics

    Post Operative Pain, Acute

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources